Cargando…
Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?
The most effective COVID-19 vaccines, to date, utilize nanotechnology to deliver immunostimulatory mRNA. However, their high cost equates to low affordability. Total nano-vaccine purchases per capita and their proportion within the total vaccine lots have increased directly with the GDP per capita o...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120867/ https://www.ncbi.nlm.nih.gov/pubmed/33988035 http://dx.doi.org/10.2217/nnm-2021-0024 |